The exon-junction complex helicase eIF4A3 holds therapeutic potential in acute myeloid leukemia

Leukemia. 2024 Mar;38(3):663-666. doi: 10.1038/s41375-023-02098-2. Epub 2023 Nov 30.

Sophia Miliara¹, Elisabetta Cozzi², Xiangfu Zhong¹, Isaac Chan¹, Karl Ekwall¹, Sören Lehmann^{2

3

4}, Andreas Lennartsson¹, Jiri Bartek^{5

6}, Dimitris C Kanellis⁷

¹ Department of Biosciences and Nutrition, Neo, Karolinska Institute, Huddinge, Sweden.
² Department of Medicine Huddinge, Center for Hematology and Regenerative Medicine, Karolinska Institute, Stockholm, Sweden.
³ Department of Medical Sciences, Hematology Unit, Uppsala University, Uppsala, Sweden.
⁴ Hematology Centre, Karolinska University Hospital, Stockholm, Sweden.
⁵ Danish Cancer Institute, Danish Cancer Society, DK-2100, Copenhagen, Denmark. jb@cancer.dk.
⁶ Department of Medical Biochemistry and Biophysics, Science for Life Laboratory, Division of Genome Biology, Karolinska Institutet, S-171 21, Stockholm, Sweden. jb@cancer.dk.
⁷ Department of Medical Biochemistry and Biophysics, Science for Life Laboratory, Division of Genome Biology, Karolinska Institutet, S-171 21, Stockholm, Sweden. dimitris.kanellis@ki.se.

No abstract available

MeSH terms